位置:首页 > 蛋白库 > IL7RA_MOUSE
IL7RA_MOUSE
ID   IL7RA_MOUSE             Reviewed;         459 AA.
AC   P16872; Q9R0C1;
DT   01-AUG-1990, integrated into UniProtKB/Swiss-Prot.
DT   27-JUL-2011, sequence version 2.
DT   03-AUG-2022, entry version 185.
DE   RecName: Full=Interleukin-7 receptor subunit alpha;
DE            Short=IL-7 receptor subunit alpha;
DE            Short=IL-7R subunit alpha;
DE            Short=IL-7R-alpha;
DE            Short=IL-7RA;
DE   AltName: CD_antigen=CD127;
DE   Flags: Precursor;
GN   Name=Il7r;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2317865; DOI=10.1016/0092-8674(90)90342-c;
RA   Goodwin R.G., Friend D., Ziegler S.F., Jerzy R., Falk B.A., Gimpel S.,
RA   Cosman D., Dower S.K., March C.J., Namen A.E., Park L.S.;
RT   "Cloning of the human and murine interleukin-7 receptors: demonstration of
RT   a soluble form and homology to a new receptor superfamily.";
RL   Cell 60:941-951(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=10556186;
RA   Lo M., Bloom M.L., Imada K., Berg M., Bollenbacher J.M., Bloom E.T.,
RA   Kelsall B.L., Leonard W.J.;
RT   "Restoration of lymphoid populations in a murine model of X-linked severe
RT   combined immunodeficiency by a gene-therapy approach.";
RL   Blood 94:3027-3036(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Thymus;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 231-239 AND 264-272.
RX   PubMed=2038316; DOI=10.1128/mcb.11.6.3052-3059.1991;
RA   Pleiman C.M., Gimpel S.D., Park L.S., Harada H., Taniguchi T.,
RA   Ziegler S.F.;
RT   "Organization of the murine and human interleukin-7 receptor genes: two
RT   mRNAs generated by differential splicing and presence of a type I-
RT   interferon-inducible promoter.";
RL   Mol. Cell. Biol. 11:3052-3059(1991).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19144319; DOI=10.1016/j.immuni.2008.11.006;
RA   Trost M., English L., Lemieux S., Courcelles M., Desjardins M.,
RA   Thibault P.;
RT   "The phagosomal proteome in interferon-gamma-activated macrophages.";
RL   Immunity 30:143-154(2009).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 21-239 IN COMPLEX WITH CRLF2 AND
RP   TSLP, AND DISULFIDE BONDS.
RX   PubMed=24632570; DOI=10.1038/nsmb.2794;
RA   Verstraete K., van Schie L., Vyncke L., Bloch Y., Tavernier J., Pauwels E.,
RA   Peelman F., Savvides S.N.;
RT   "Structural basis of the proinflammatory signaling complex mediated by
RT   TSLP.";
RL   Nat. Struct. Mol. Biol. 21:375-382(2014).
CC   -!- FUNCTION: Receptor for interleukin-7. Also acts as a receptor for
CC       thymic stromal lymphopoietin (TSLP).
CC   -!- SUBUNIT: The IL7 receptor is a heterodimer of IL7R and IL2RG. The TSLP
CC       receptor is a heterodimer of CRLF2 and IL7R.
CC       {ECO:0000269|PubMed:24632570}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein.
CC   -!- TISSUE SPECIFICITY: Spleen, thymus and fetal liver.
CC   -!- DOMAIN: The WSXWS motif appears to be necessary for proper protein
CC       folding and thereby efficient intracellular transport and cell-surface
CC       receptor binding.
CC   -!- DOMAIN: The box 1 motif is required for JAK interaction and/or
CC       activation.
CC   -!- PTM: N-glycosylated IL-7Ralpha binds IL7 300-fold more tightly than the
CC       unglycosylated form. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the type I cytokine receptor family. Type 4
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M29697; AAA39304.1; -; mRNA.
DR   EMBL; AF078906; AAF06717.1; -; mRNA.
DR   EMBL; AK042264; BAC31208.1; -; mRNA.
DR   EMBL; CH466581; EDL03312.1; -; Genomic_DNA.
DR   CCDS; CCDS27376.1; -.
DR   PIR; D34791; D34791.
DR   RefSeq; NP_032398.3; NM_008372.4.
DR   PDB; 4NN5; X-ray; 1.90 A; B=21-239.
DR   PDB; 4NN6; X-ray; 2.54 A; B=21-239.
DR   PDB; 4NN7; X-ray; 3.78 A; B=21-239.
DR   PDB; 5J12; X-ray; 3.55 A; B=21-239.
DR   PDBsum; 4NN5; -.
DR   PDBsum; 4NN6; -.
DR   PDBsum; 4NN7; -.
DR   PDBsum; 5J12; -.
DR   AlphaFoldDB; P16872; -.
DR   SMR; P16872; -.
DR   DIP; DIP-59472N; -.
DR   IntAct; P16872; 3.
DR   STRING; 10090.ENSMUSP00000003981; -.
DR   GlyGen; P16872; 3 sites.
DR   iPTMnet; P16872; -.
DR   PhosphoSitePlus; P16872; -.
DR   EPD; P16872; -.
DR   PaxDb; P16872; -.
DR   PRIDE; P16872; -.
DR   ProteomicsDB; 266970; -.
DR   Antibodypedia; 4129; 1310 antibodies from 47 providers.
DR   DNASU; 16197; -.
DR   Ensembl; ENSMUST00000003981; ENSMUSP00000003981; ENSMUSG00000003882.
DR   GeneID; 16197; -.
DR   KEGG; mmu:16197; -.
DR   UCSC; uc007vfo.2; mouse.
DR   CTD; 3575; -.
DR   MGI; MGI:96562; Il7r.
DR   VEuPathDB; HostDB:ENSMUSG00000003882; -.
DR   eggNOG; ENOG502S4WE; Eukaryota.
DR   GeneTree; ENSGT00510000048500; -.
DR   HOGENOM; CLU_045398_0_0_1; -.
DR   InParanoid; P16872; -.
DR   OMA; QIHRVDD; -.
DR   OrthoDB; 617812at2759; -.
DR   PhylomeDB; P16872; -.
DR   TreeFam; TF336573; -.
DR   Reactome; R-MMU-1266695; Interleukin-7 signaling.
DR   Reactome; R-MMU-8856825; Cargo recognition for clathrin-mediated endocytosis.
DR   Reactome; R-MMU-8856828; Clathrin-mediated endocytosis.
DR   BioGRID-ORCS; 16197; 1 hit in 74 CRISPR screens.
DR   ChiTaRS; Il7r; mouse.
DR   PRO; PR:P16872; -.
DR   Proteomes; UP000000589; Chromosome 15.
DR   RNAct; P16872; protein.
DR   Bgee; ENSMUSG00000003882; Expressed in peripheral lymph node and 78 other tissues.
DR   ExpressionAtlas; P16872; baseline and differential.
DR   Genevisible; P16872; MM.
DR   GO; GO:0005829; C:cytosol; ISO:MGI.
DR   GO; GO:0009897; C:external side of plasma membrane; IDA:MGI.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005654; C:nucleoplasm; ISO:MGI.
DR   GO; GO:0005886; C:plasma membrane; ISO:MGI.
DR   GO; GO:0004896; F:cytokine receptor activity; ISO:MGI.
DR   GO; GO:0001782; P:B cell homeostasis; IGI:MGI.
DR   GO; GO:0042100; P:B cell proliferation; IMP:MGI.
DR   GO; GO:0000902; P:cell morphogenesis; IGI:MGI.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; IBA:GO_Central.
DR   GO; GO:0050830; P:defense response to Gram-positive bacterium; IMP:UniProtKB.
DR   GO; GO:0010467; P:gene expression; IMP:MGI.
DR   GO; GO:0030097; P:hemopoiesis; IBA:GO_Central.
DR   GO; GO:0048535; P:lymph node development; IMP:MGI.
DR   GO; GO:0070233; P:negative regulation of T cell apoptotic process; IMP:MGI.
DR   GO; GO:0001915; P:negative regulation of T cell mediated cytotoxicity; IMP:MGI.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; ISO:MGI.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:MGI.
DR   GO; GO:0046427; P:positive regulation of receptor signaling pathway via JAK-STAT; IBA:GO_Central.
DR   GO; GO:1904894; P:positive regulation of receptor signaling pathway via STAT; ISO:MGI.
DR   GO; GO:0033089; P:positive regulation of T cell differentiation in thymus; IMP:MGI.
DR   GO; GO:0008361; P:regulation of cell size; IDA:MGI.
DR   GO; GO:0030217; P:T cell differentiation; IMP:MGI.
DR   GO; GO:0033077; P:T cell differentiation in thymus; IMP:MGI.
DR   GO; GO:0043029; P:T cell homeostasis; IMP:MGI.
DR   GO; GO:0001913; P:T cell mediated cytotoxicity; IMP:MGI.
DR   CDD; cd00063; FN3; 1.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR040997; FN3_7.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR003531; Hempt_rcpt_S_F1_CS.
DR   InterPro; IPR013783; Ig-like_fold.
DR   Pfam; PF00041; fn3; 1.
DR   Pfam; PF18447; FN3_7; 1.
DR   SUPFAM; SSF49265; SSF49265; 1.
DR   PROSITE; PS50853; FN3; 1.
DR   PROSITE; PS01355; HEMATOPO_REC_S_F1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Disulfide bond; Glycoprotein; Membrane; Phosphoprotein;
KW   Receptor; Reference proteome; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..20
FT   CHAIN           21..459
FT                   /note="Interleukin-7 receptor subunit alpha"
FT                   /id="PRO_0000010910"
FT   TOPO_DOM        21..239
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        240..264
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        265..459
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          131..232
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   REGION          337..365
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          378..413
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           218..222
FT                   /note="WSXWS motif"
FT   MOTIF           272..280
FT                   /note="Box 1 motif"
FT   COMPBIAS        343..360
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         282
FT                   /note="Phosphothreonine; by PKC"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        60
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        115
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        177
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        42..57
FT                   /evidence="ECO:0000269|PubMed:24632570"
FT   DISULFID        74..82
FT                   /evidence="ECO:0000269|PubMed:24632570"
FT   DISULFID        108..118
FT                   /evidence="ECO:0000269|PubMed:24632570"
FT   CONFLICT        299..302
FT                   /note="NPES -> IPEI (in Ref. 1; AAA39304)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        322
FT                   /note="S -> I (in Ref. 1; AAA39304)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        431
FT                   /note="V -> F (in Ref. 1; AAA39304)"
FT                   /evidence="ECO:0000305"
FT   STRAND          40..51
FT                   /evidence="ECO:0007829|PDB:4NN5"
FT   STRAND          53..60
FT                   /evidence="ECO:0007829|PDB:4NN5"
FT   STRAND          69..79
FT                   /evidence="ECO:0007829|PDB:4NN5"
FT   STRAND          81..84
FT                   /evidence="ECO:0007829|PDB:4NN5"
FT   STRAND          86..88
FT                   /evidence="ECO:0007829|PDB:4NN5"
FT   STRAND          91..97
FT                   /evidence="ECO:0007829|PDB:4NN5"
FT   STRAND          101..103
FT                   /evidence="ECO:0007829|PDB:4NN5"
FT   STRAND          105..111
FT                   /evidence="ECO:0007829|PDB:4NN5"
FT   STRAND          114..121
FT                   /evidence="ECO:0007829|PDB:4NN5"
FT   HELIX           123..125
FT                   /evidence="ECO:0007829|PDB:4NN5"
FT   STRAND          126..128
FT                   /evidence="ECO:0007829|PDB:4NN5"
FT   STRAND          133..140
FT                   /evidence="ECO:0007829|PDB:4NN5"
FT   TURN            141..144
FT                   /evidence="ECO:0007829|PDB:4NN5"
FT   STRAND          145..151
FT                   /evidence="ECO:0007829|PDB:4NN5"
FT   HELIX           153..156
FT                   /evidence="ECO:0007829|PDB:4NN5"
FT   STRAND          157..159
FT                   /evidence="ECO:0007829|PDB:4NN5"
FT   STRAND          163..174
FT                   /evidence="ECO:0007829|PDB:4NN5"
FT   STRAND          179..191
FT                   /evidence="ECO:0007829|PDB:4NN5"
FT   HELIX           192..194
FT                   /evidence="ECO:0007829|PDB:4NN5"
FT   STRAND          200..209
FT                   /evidence="ECO:0007829|PDB:4NN5"
FT   STRAND          225..228
FT                   /evidence="ECO:0007829|PDB:4NN5"
SQ   SEQUENCE   459 AA;  51605 MW;  52ADF78C8C01D2EE CRC64;
     MMALGRAFAI VFCLIQAVSG ESGNAQDGDL EDADADDHSF WCHSQLEVDG SQHLLTCAFN
     DSDINTANLE FQICGALLRV KCLTLNKLQD IYFIKTSEFL LIGSSNICVK LGQKNLTCKN
     MAINTIVKAE APSDLKVVYR KEANDFLVTF NAPHLKKKYL KKVKHDVAYR PARGESNWTH
     VSLFHTRTTI PQRKLRPKAM YEIKVRSIPH NDYFKGFWSE WSPSSTFETP EPKNQGGWDP
     VLPSVTILSL FSVFLLVILA HVLWKKRIKP VVWPSLPDHK KTLEQLCKKP KTSLNVSFNP
     ESFLDCQIHE VKGVEARDEV ESFLPNDLPA QPEELETQGH RAAVHSANRS PETSVSPPET
     VRRESPLRCL ARNLSTCNAP PLLSSRSPDY RDGDRNRPPV YQDLLPNSGN TNVPVPVPQP
     LPFQSGILIP VSQRQPISTS SVLNQEEAYV TMSSFYQNK
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024